Title: Increased activation of the alternative 'backdoor' pathway in patients with 21-hydroxylase deficiency: evidence from urinary steroid hormone analysis.
Journal: The Journal of clinical endocrinology and metabolism 20120301
1138-52-9
17696-37-6
2217-60-9
88-58-4
497-39-2
499-75-2
741667-07-2 | 1-(2-Propoxyethyl)piperazine | AA005NVE | MFCD04117823
67950-95-2 | 1-(Carboxymethyl)cyclohexane-1-carboxylic acid | AA005OMJ | MFCD04037521
68573-23-9 | N-[2-(5-hydroxy-1H-indol-3-yl)ethyl]-3-(4-hydroxy-3-methoxy-phenyl)prop-2-enamide | AA005P8A | MFCD28125425
73221-18-8 | Imidazo[1,2-a]pyridin-8-ylamine | AA005PXG | MFCD06739233
676596-63-7 | 7,8-DIHYDRO-5H-PYRIDO[3,2-B]AZEPINE-6,9-DIONE | AA005QUA | MFCD09817624
76167-42-5 | Pyrimidine, 2-((1-benzyl-4-piperidyl)amino)- | AA005RLI | MFCD01689888
760212-58-6 | 1-(4-Bromophenyl)-2-phenyl-1h-benzo[d]imidazole | AA005S9Q | MFCD09746342
7153-60-8 | 1-butyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidine-5-carbonitrile | AA005SVS | MFCD01927078
94985-27-0 | 1-Benzyl-3-azetidinecarboxylic acid | AA005TIO | MFCD06752277
98891-36-2 | L-Homopropargylglycine | AA005TLT | MFCD11052896